Sitemap - 2016 - Mendelspod
Genomics in 2016: Nathan and Laura Name Their Top Stories
Hank Greely on “The End of Sex" and Other Stuff
How to Scale Cancer Genomics, with Marco Marra, UBC
What Does the Election Mean for Genomics? November 2016 with Nathan and Laura
The Saga Continues: Ethan Perlstein, Indie Scientist, Part 3
Biomarker Panel to Predict Type 1 Diabetes
Can You Name the World’s Largest Single Disease Research Charity?
Why Diversity Is the Only Path Forward: Sarah Tishkoff on African Genomics
October 2016 with Nathan and Laura
We’re Over Halfway There: Baylor's Richard Gibbs on Clinical Genetics
With FDA Guidance on LDTs Still Not Out, What Are Labs Doing?
Reference Genome Making Major Strides in Ethnic Diversity, Says Valerie Schneider, NCBI
September 2016 with Nathan and Laura
Luke Timmerman on His New Biography of Lee Hood
Digital PCR Opens Up New Liquid Biopsy Opportunity in Melanoma Treatment: David Polsky, NYU
Erica Ramos on Her Pioneering Role as Genetic Counselor for Industry
August 2016 with Nathan and Laura
A Maniacal Commitment to Science: Peering into Regeneron’s Genetics Center with Jeff Reid
The Days of Miracle and Wonder: Laura Hercher on Genetic Counseling, Part 2
The Days of Miracle and Wonder: Laura Hercher on Genetic Counseling, Part 1
A Precision Medicine Platform Comes of Age: Jonathan Hirsch, Syapse
FDA’s Liz Mansfield on New NGS Guidances
How Is the Brexit Impacting Genomics? with Clare Turnbull and Hadyn Parry
June 2016 with Nathan and Laura: GMO Labeling, Misspelling CRISPR, Sequenom Patent Loss, SmidgIon
Know Then Thyself: Kari Stefansson, deCODE genetics
Sequenom Patent Loss a Threat to Personalized Medicine, Says Kevin Noonan
Bringing Home Some Diagnostics Gold: Brad Gray, NanoString Show How It’s Done
The Solid Future of Liquid Biopsies with Michael Nall, Biocept
Genomics Is Oversubscribed, Says Creator of BLAST
With 10K Genomes Sequenced, Genomics England in High Gear: Clare Turnbull, Clinical Lead
A Sneak Peek into the Future of Clinical Genomics with Ben Solomon, Inova
Preprints and the Future of Science Publishing with Jason Hoyt, PeerJ
Flipping Drug Development Upside Down: Niven Narain, BERG Health
Medicine and the Limits of Science with Michel Accad, MD
How Good are Linked Reads? Serge Saxonov, 10X Genomics
A Home Run on the First Hit: PacBio’s Jonas Korlach
Digital Pathology at Scale: Epic Sciences Takes CTC Technology to the Next Level
February 2016: Mosquitos, Preprints, and that Rocking White House Summit
Is Oxitec Ready to Scale as Governments Seek Options to Control the Zika Virus?
Human Genome Turns 15: Mike Hunkapiller
January 2016: Landergate, Grail, and Cancer Moonshot
Frontiers of Sequencing: Putting Long Reads and Graph Assemblies to Work